Table 1.

Clinical and endoscopic variables of patients at study entry (n = 76, mean±SD)

	Epinephrine (20 mL) n (%)	Epinephrine (30 mL) n (%)	Epinephrine (40 mL) n (%)
Age (yr)	61.5 ± 12.8	60.2 ± 13.3	62.3 ± 12.5
Gender (M/F)	56/20	53/23	55/21
NSAID ingestion	26 (34.2)	24 (31.6)	27 (35.5)
Shock	20 (26.3)	23 (30.3)	21 (27.6)
Comorbid illness	43 (56.6)	41 (53.9)	45 (59.2)
Hb level (g/dL)	7.2 ± 2.8	7.5 ± 2.6	7.6 ± 2.7
Coagulopathy	12 (15.8)	10 (13.2)	13 (17.1)
Positive H pylori	44 (57.9)	43 (56.6)	47 (61.8)
Forrest class
Ia	18 (23.7)	20 (26.3)	19 (25.0)
Ib	58 (76.3)	56 (73.7)	57 (75.0)
Ulcer size
≥2 cm	20 (26.3)	22 (28.9)	23 (30.3)
<2 cm	56 (73.7)	54 (71.1)	53 (69.7)
Location of ulcer
Stomach	41 (53.9)	40 (52.6)	44 (57.9)
Duodenum	32 (42.1)	34 (44.7)	30 (39.5)
Stoma	3 (3.9)	2 (2.6)	2 (2.6)

NSAID: non-steroid anti-inflammatory drug. P > 0.05 for all variables between the three groups.